Innate Pharma SA Weighted Average Shares
Innate Pharma SA (IPHA) reported Weighted Average Shares of 89.59 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageShares · last filed 2026-04-01
| Period end | Weighted Average Shares 6 month | Weighted Average Shares 12 month |
|---|---|---|
| 2025-12-31 | 89.59M shares 20-F · filed 2026-04-01 | |
| 2025-06-30 | 86.94M shares 6-K · filed 2025-09-17 | |
| 2024-12-31 | 81.05M shares 20-F · filed 2026-04-01 | |
| 2024-06-30 | 80.87M shares 6-K · filed 2025-09-17 | |
| 2023-12-31 | 80.45M shares 20-F · filed 2026-04-01 | |
| 2023-06-30 | 80.32M shares 6-K · filed 2024-09-12 | |
| 2022-12-31 | 79.64M shares 20-F · filed 2025-04-30 | |
| 2022-06-30 | 79.75M shares 6-K · filed 2023-09-14 | |
| 2021-12-31 | 79.54M shares 20-F · filed 2024-04-04 | |
| 2021-06-30 | 79.00M shares 6-K · filed 2022-09-15 | |
| 2020-12-31 | 78.93M shares 20-F · filed 2023-04-06 | |
| 2020-06-30 | 78.89M shares 6-K · filed 2021-09-15 | |
| 2019-12-31 | 66.91M shares 20-F · filed 2022-04-04 | |
| 2018-12-31 | 58.78M shares 20-F · filed 2021-04-27 | |
| 2017-12-31 | 54.35M shares 20-F · filed 2020-04-24 |